Market revenue in 2023 | USD 1,202.2 million |
Market revenue in 2030 | USD 1,822.1 million |
Growth rate | 6.1% (CAGR from 2023 to 2030) |
Largest segment | Consulting |
Fastest growing segment | Training & Education |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Consulting was the largest segment with a revenue share of 56.9% in 2023. Horizon Databook has segmented the Australia biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
Moreover, the rapid adoption of outsourcing manufacturing technologies and advanced processes further enhances efficiency, reduces costs, and improves the quality & quantity of drug production.
Furthermore, adopting advanced manufacturing technologies and processes can enhance efficiency, reduce costs, and improve the quality of pharmaceutical & biotechnology drugs. This is expected to support the demand for the market in Australia and create opportunities for CMOs & CDMOs in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Australia biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account